Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A National Strategy to Diagnose Coronavirus Disease 2019–Associated Invasive Fungal Disease in the Intensive Care Unit
P. Lewis White, Rishi Dhillon, Alan Cordey, et al.
Clinical Infectious Diseases (2020) Vol. 73, Iss. 7, pp. e1634-e1644
Open Access | Times Cited: 414

Showing 1-25 of 414 citing articles:

Defining and managing COVID-19-associated pulmonary aspergillosis: the 2020 ECMM/ISHAM consensus criteria for research and clinical guidance
Philipp Koehler, Matteo Bassetti, Arunaloke Chakrabarti, et al.
The Lancet Infectious Diseases (2020) Vol. 21, Iss. 6, pp. e149-e162
Open Access | Times Cited: 767
Rhino-Orbital Mucormycosis Associated With COVID-19
Salil Mehta, Abha Pandey
Cureus (2020)
Open Access | Times Cited: 574
Prevalence and outcomes of co-infection and superinfection with SARS-CoV-2 and other pathogens: A systematic review and meta-analysis
Jackson Musuuza, Lauren Watson, Vishala Parmasad, et al.
PLoS ONE (2021) Vol. 16, Iss. 5, pp. e0251170-e0251170
Open Access | Times Cited: 431
Post coronavirus disease mucormycosis: a deadly addition to the pandemic spectrum
S Sharma, Mohnish Grover, Shruti Bhargava, et al.
The Journal of Laryngology & Otology (2021) Vol. 135, Iss. 5, pp. 442-447
Open Access | Times Cited: 386
COVID-19-associated fungal infections
Martin Hoenigl, Danila Seidel, Rosanne Sprute, et al.
Nature Microbiology (2022) Vol. 7, Iss. 8, pp. 1127-1140
Open Access | Times Cited: 327
COVID-19-Associated Candidiasis (CAC): An Underestimated Complication in the Absence of Immunological Predispositions?
Amir Arastehfar, Agostinho Carvalho, M. Hong Nguyen, et al.
Journal of Fungi (2020) Vol. 6, Iss. 4, pp. 211-211
Open Access | Times Cited: 244
SARS-CoV-2 infection induces the dedifferentiation of multiciliated cells and impairs mucociliary clearance
Rémy Robinot, Mathieu Hubert, Guilherme Dias de Melo, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 212
Risk factors and outcome of pulmonary aspergillosis in critically ill coronavirus disease 2019 patients—a multinational observational study by the European Confederation of Medical Mycology
Juergen Prattes, Joost Wauters, Daniele Roberto Giacobbe, et al.
Clinical Microbiology and Infection (2021) Vol. 28, Iss. 4, pp. 580-587
Open Access | Times Cited: 187
Aspergillosis Complicating Severe Coronavirus Disease
Kieren A. Marr, Andrew Platt, Jeffrey A. Tornheim, et al.
Emerging infectious diseases (2020) Vol. 27, Iss. 1, pp. 18-25
Open Access | Times Cited: 163
Occurrence of Invasive Pulmonary Fungal Infections in Patients with Severe COVID-19 Admitted to the ICU
Arnaud Fekkar, Alexandre Lampros, Julien Mayaux, et al.
American Journal of Respiratory and Critical Care Medicine (2020) Vol. 203, Iss. 3, pp. 307-317
Open Access | Times Cited: 158
Aspergillus fumigatusand aspergillosis: From basics to clinics
Amir Arastehfar, Agostinho Carvalho, Jos Houbraken, et al.
Studies in Mycology (2021) Vol. 100, Iss. 1, pp. 100115-100115
Open Access | Times Cited: 156
State-of-the-art review of secondary pulmonary infections in patients with COVID-19 pneumonia
Woon H. Chong, Biplab K. Saha, Ananthakrishnan Ramani, et al.
Infection (2021) Vol. 49, Iss. 4, pp. 591-605
Open Access | Times Cited: 155
Mucormycosis in patients with COVID‐19: A cross‐sectional descriptive multicentre study from Iran
Farzad Pakdel, Kazem Ahmadikia, Mohammadreza Salehi, et al.
Mycoses (2021) Vol. 64, Iss. 10, pp. 1238-1252
Open Access | Times Cited: 149
Risk factors associated with COVID-19-associated pulmonary aspergillosis in ICU patients: a French multicentric retrospective cohort
Sarah Dellière, Emmanuel Dudoignon, Sofiane Fodil, et al.
Clinical Microbiology and Infection (2020) Vol. 27, Iss. 5, pp. 790.e1-790.e5
Open Access | Times Cited: 148
Fungal infections in mechanically ventilated patients with COVID-19 during the first wave: the French multicentre MYCOVID study
Jean‐Pierre Gangneux, Éric Dannaoui, Arnaud Fekkar, et al.
The Lancet Respiratory Medicine (2021) Vol. 10, Iss. 2, pp. 180-190
Open Access | Times Cited: 144
Taskforce report on the diagnosis and clinical management of COVID-19 associated pulmonary aspergillosis
Paul E. Verweij, Roger J. M. Brüggemann, Élie Azoulay, et al.
Intensive Care Medicine (2021) Vol. 47, Iss. 8, pp. 819-834
Open Access | Times Cited: 134
Incidence, diagnosis and outcomes of COVID-19-associated pulmonary aspergillosis (CAPA): a systematic review
Woon H. Chong, Kristoffer Neu
Journal of Hospital Infection (2021) Vol. 113, pp. 115-129
Open Access | Times Cited: 122
Mucormycosis after Coronavirus disease 2019 infection in a heart transplant recipient – Case report and review of literature
Akshay Khatri, Kai‐Ming Chang, Ilan Berlinrut, et al.
Journal de Mycologie Médicale (2021) Vol. 31, Iss. 2, pp. 101125-101125
Open Access | Times Cited: 118
Multinational Observational Cohort Study of COVID-19–Associated Pulmonary Aspergillosis1
Nico Janssen, Rémy Nyga, Lore Vanderbeke, et al.
Emerging infectious diseases (2021) Vol. 27, Iss. 11, pp. 2892-2898
Open Access | Times Cited: 110
Defining COVID-19–associated pulmonary aspergillosis: systematic review and meta-analysis
Ruwandi Kariyawasam, Tanis C. Dingle, Brittany Kula, et al.
Clinical Microbiology and Infection (2022) Vol. 28, Iss. 7, pp. 920-927
Open Access | Times Cited: 72
Therapeutics for COVID-19 and post COVID-19 complications: An update
Debdoot Basu, Vivek P. Chavda, Anita A. Mehta
Current Research in Pharmacology and Drug Discovery (2022) Vol. 3, pp. 100086-100086
Open Access | Times Cited: 68
Invasive Aspergillosis in the Intensive Care Unit
Anna Zubovskaia, José A. Vázquez
Journal of Fungi (2025) Vol. 11, Iss. 1, pp. 70-70
Open Access | Times Cited: 1
Invasive Fungal Disease Complicating Coronavirus Disease 2019: When It Rains, It Spores
Martin Hoenigl
Clinical Infectious Diseases (2020) Vol. 73, Iss. 7, pp. e1645-e1648
Open Access | Times Cited: 121
Candidemia in Coronavirus Disease 2019 (COVID-19) Patients: Incidence and Characteristics in a Prospective Cohort Compared With Historical Non–COVID-19 Controls
Andrea Mastrángelo, Bruno Germinario, Marica Ferrante, et al.
Clinical Infectious Diseases (2020) Vol. 73, Iss. 9, pp. e2838-e2839
Open Access | Times Cited: 102
Autopsy Proven Pulmonary Mucormycosis Due to Rhizopus microsporus in a Critically Ill COVID-19 Patient with Underlying Hematological Malignancy
Christoph Zurl, Martin Hoenigl, Eduard Schulz, et al.
Journal of Fungi (2021) Vol. 7, Iss. 2, pp. 88-88
Open Access | Times Cited: 98
Page 1 - Next Page

Scroll to top